Table of Contents Author Guidelines Submit a Manuscript
Journal of Interventional Cardiology
Volume 2019, Article ID 6548696, 8 pages
https://doi.org/10.1155/2019/6548696
Research Article

Drug Coated Balloon-Only Strategy in De Novo Lesions of Large Coronary Vessels

1Klinikum Aschaffenburg-Alzenau, Medizinische Klinik 1, Aschaffenburg, Germany
2Medical Scientific Affairs, B. Braun Melsungen AG, Berlin, Germany
3Department of Cardiology and Internal Medicine, Charité–Universitätsmedizin Berlin, Campus Virchow, Berlin, Germany
4Pantai Hospital, Kuala Lumpur, Malaysia
5Pusat Perutban Universiti, Malaysia
6Ospedale San Giovanni di Dio, Italy
7The National Heart Institute of Malaysia, Malaysia
8Hospital Queen Elizabeth II, Malaysia
9Pusat Perutban Universiti Kebangsaan, Malaysia
10Espirito Santo Evora, Portugal
11CHU Montpellier, France
12Innere Medizin III, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Germany

Correspondence should be addressed to Mark Rosenberg; ed.zla-ba-mukinilk@grebnesor.kram

Received 5 November 2018; Revised 7 January 2019; Accepted 17 January 2019; Published 3 February 2019

Academic Editor: Gianluca Campo

Copyright © 2019 Mark Rosenberg et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. W. Serruys, H. M. Garcia-Garcia, and Y. Onuma, “From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?” European Heart Journal, vol. 33, no. 1, pp. 16–25, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Rosenberg, M. Waliszewski, K. Chin et al., “Prospective, Large-Scale Multicenter Trial for the Use of Drug Coated Balloons (DCB) in Coronary Lesions: The DCB-Only All-Comers Registry,” Catheterization and Cardiovascular Interventions, 2018. View at Publisher · View at Google Scholar
  3. J. Wöhrle, M. Zadura, S. Möbius-Winkler et al., “SeQuent please world wide registry: Clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study,” Journal of the American College of Cardiology, vol. 60, no. 18, pp. 1733–1738, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. U. Zeymer, M. Waliszewski, M. Spiecker et al., “Prospective 'real world' registry for the use of the 'PCB only' strategy in small vessel de novo lesions,” Heart, vol. 100, no. 4, pp. 311–316, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Waksman, A. Serra, J. P. Loh et al., “Drug-coated balloons for de novo coronary lesions: Results from the Valentines II trial,” EuroIntervention, vol. 9, no. 5, pp. 613–619, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. R. V. Jeger, A. Farah, M. A. Ohlow, BASKET-SMALL 2 Investigators et al., “Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial,” Lancet, vol. 392, no. 10150, pp. 849–856, 2018. View at Google Scholar
  7. M. Megaly, M. Rofael, M. Saad et al., “Outcomes with drug‐coated balloons in small‐vessel coronary artery disease,” Catheterization and Cardiovascular Interventions, 2018. View at Publisher · View at Google Scholar
  8. U. Zeymer and B. Scheller, “PCI in small vessels: The case for a drug-coated balloon based intervention,” EuroIntervention, vol. 7, pp. K57–K60, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. F. X. Kleber, H. Rittger, K. Bonaventura et al., “Drug-coated balloons for treatment of coronary artery disease: Updated recommendations from a consensus group,” Clinical Research in Cardiology, vol. 102, no. 11, pp. 785–797, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. G. W. Stone, A. Rizvi, W. Newman et al., “Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease,” The New England Journal of Medicine, vol. 362, no. 18, pp. 1663–1674, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Biondi-Zoccai, C. Moretti, A. Abbate, and I. Sheiban, “Percutaneous coronary intervention for small vessel coronary artery disease,” Cardiovascular Revascularization Medicine, vol. 11, no. 3, pp. 189–198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. “Coronary Artery angiographic changes after PTCA: Manual of Operations NHBLI PTCA Registry 6:9,” 1985.
  13. D. E. Cutlip, S. Windecker, R. Mehran et al., “Clinical end points in coronary stent trials: a case for standardized definitions,” Circulation, vol. 115, no. 17, pp. 2344–2351, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Unverdorben, F. X. Kleber, H. Heuer et al., “Treatment of small coronary arteries with a paclitaxel-coated balloon catheter,” Clinical Research in Cardiology, vol. 99, no. 3, pp. 165–174, 2010. View at Publisher · View at Google Scholar
  15. B. Cortese, A. Micheli, A. Picchi et al., “Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study,” Heart, vol. 96, no. 16, pp. 1291–1296, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Toelg, B. Merkely, A. Erglis et al., “Coronary artery treatment with paclitaxel-coated balloon using a BTHC excipient: Clinical results of the international real-world DELUX registry,” EuroIntervention, vol. 10, no. 5, pp. 591–599, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Puymirat, T. Simon, G. Cayla et al., “Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-elevation Myocardial Infarction) 1995 to 2015,” Circulation, vol. 136, no. 20, pp. 1908–1919, 1995. View at Google Scholar
  18. B. Ibanez, S. James, S. Agewall, ESC Scientific Document Group et al., “2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC),” European Heart Journal, vol. 39, no. 2, pp. 119–177, 2018. View at Google Scholar
  19. M. Roffi, C. Patrono, J.-P. Collet, ESC Scientific Document Group et al., “2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC),” European Heart Journal, vol. 37, no. 3, pp. 267–315, 2016. View at Publisher · View at Google Scholar
  20. S. Elezi, A. Kastrati, F.-J. Neumann, M. Hadamitzky, J. Dirschinger, and A. Schömig, “Vessel size and long-term outcome after coronary stent placement,” Circulation, vol. 98, no. 18, pp. 1875–1880, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. J. A. Ormiston, M. A. Turco, J. J. Hall et al., “Long-term benefit of the TAXUS liberté stent in small vessels and long lesions - TAXUS ATLAS program,” Circulation Journal, vol. 75, no. 5, pp. 1120–1129, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. S. G. Ellis, D. J. Kereiakes, D. C. Metzger et al., “Everolimus-eluting bioresorbable scaffolds for coronary artery disease,” The New England Journal of Medicine, vol. 373, no. 20, pp. 1905–1915, 2015. View at Publisher · View at Google Scholar · View at Scopus